Nova Patents
AT320808T

Novel metalloporphyrins and their uses as radiosensitizers for radiation therapy

Abstract

The invention relates to a plurality carborane cages' boronise porphyrin halogenate derivatives as the active ingredient the radiosensitizer, the radiosensitizer selectively is a radiating the tumour tissue in area, and can therefore be used for treating cancer, comprising, and not limited to the boron neutron of therapy and photodynamic therapy. The invention further claims an tumour from and cancer treatment are radiosensitizers the method.

Term

No projected expiry on record.

  1. Priority
  2. Filed
  3. Granted
  4. Today

32 members in 17 offices

This recordMember, by publication datePriority claim7 more offices are in the list below

Priority claims2

Priority claims
DocumentOfficeKindDate
87420301United States of AmericaA
11701002United States of AmericaA

Members32

Family members, oldest first
DocumentOfficeKind
CA2449316A1CanadaA1
WO02098417A1World Intellectual Property Organization (WIPO)A1
US2003032799A1United States of AmericaA1
US2003083494A1United States of AmericaA1
US6566517B2United States of AmericaB2
US2003165426A1United States of AmericaA1
GB0400163D0United KingdomD0
GB2393123AUnited KingdomA
EP1404319A1European Patent Office (EPO)A1
KR20040032108ARepublic of KoreaA
US6759403B2United States of AmericaB2
ZA200400056BSouth AfricaB
GB2393123BUnited KingdomB
JP2005504012AJapanA
EP1404319A4European Patent Office (EPO)A4
CN1620289AChinaA
RU2003138076ARussian FederationA
US6951640B2United States of AmericaB2
HK1078472A1Hong Kong, ChinaA1
EP1404319B1European Patent Office (EPO)B1
AT320808TThis recordAustriaT
ATE320808T1AustriaT1
DE60210074D1GermanyD1
AU2002310314B2AustraliaB2
DK1404319T3DenmarkT3
ES2257554T3SpainT3
PT1404319EPortugalE
CN1279907CChinaC
DE60210074T2GermanyT2
RU2310447C2Russian FederationC2
JP4247110B2JapanB2
KR100899752B1Republic of KoreaB1